1. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Issue 2 (February 2020) Authors: Migden, Michael R; Khushalani, Nikhil I; Chang, Anne Lynn S; Lewis, Karl D; Schmults, Chrysalyne D; Hernandez-Aya, Leonel; Meier, Friedegund; Schadendorf, Dirk; Guminski, Alexander; Hauschild, Axel; Wong, Deborah J; Daniels, Gregory A; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; B... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. Issue 1 (17th June 2020) Authors: Rischin, Danny; Migden, Michael R; Lim, Annette M; Schmults, Chrysalyne D; Khushalani, Nikhil I; Hughes, Brett G M; Schadendorf, Dirk; Dunn, Lara A; Hernandez-Aya, Leonel; Chang, Anne Lynn S; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C; Geiger, Je... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗